Congress 2014 has ended
Back To Schedule
Friday, May 2 • 6:30pm - 8:30pm
Establishing a Plan for Length of Therapy in Multiple Myeloma

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

This program will discuss how clinical evidence supports the use of VELCADE (bortezomib) in patients with previously untreated and relapsed multiple myeloma. Attendees will learn how to establish a plan for length of therapy with VELCADE, as well as patient management strategies, including subcutaneous administration.

Registration opens at 6:30 pm, with the program to start at 6:45 pm. To register in advance, please email epic@theselvagroup.com.

This is hosted by Millennium: The Takeda Oncology Company. 

Friday May 2, 2014 6:30pm - 8:30pm PDT
Ruth's Chris Steakhouse 2041 S. Harbor Blvd, Anaheim, CA 92802
  Industry Event
  • CNE Status No CNE
  • Contact Hours of CNE: N/A

Attendees (0)